Get the latest tech news
Smart ring maker Ultrahuman has its eye on Oura’s crown
India's Ultrahuman is prepping for a growth tear. Today it's announcing the close of $35 million in Series B* funding, a mix of equity ($25M) and debt. India's Ultrahuman is prepping for a growth tear. Today it's announcing the close of $35 million in Series B* funding, a mix of equity ($25M) and debt.
Kumar also emphasizes the team’s commitment to speedy product development and iteration, and a fast scramble on geographical expansion — pushing the wearable into over 100 markets globally, some of which are akin to virgin territory as he says they don’t yet have an established smart ring leader — as contributing factors to building momentum. While some in the medical profession continue to throw doubts on the benefits of healthy people tracking their blood sugar levels, Ultrahuman can now point to the results of a clinical study it’s conducted over the past couple of years, just published in Nature, which tested its app’s metabolic scoring in a group of non-diabetics and pre-diabetics and found the digital intervention could positively influence glucose management. While smartwatch category leader Apple has yet to push deeper into health tech tracking — despite long-running rumors of R&D efforts aimed at developing a non-invasive blood glucose monitor (not to mention patents hinting at future health-tracking AirPods).
Or read this on TechCrunch
